Trial Profile
Methodology Study To Assess The Ability Of A Randomized, Double-Blind, Placebo-Controlled, Two Period Crossover Study To Detect The Efficacy Of Pregabalin In Post-Traumatic Neuropathic Pain Patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Feb 2021
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Sponsors Pfizer; Viatris Inc
- 02 Mar 2009 Actual patient numbers (25) added as reported by ClinicalTrials.gov.
- 02 Mar 2009 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.
- 02 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.